<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>University of Isfahan</PublisherName>
				<JournalTitle>Journal of Microbial Biology</JournalTitle>
				<Issn>3060-7647</Issn>
				<Volume>3</Volume>
				<Issue>12</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>01</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Prevalence of CTX-M-Type β-Lactamases in Multi-Drug Resistant Escherichia coli Isolates from North of Iran, Rasht</ArticleTitle>
<VernacularTitle>Prevalence of CTX-M-Type β-Lactamases in Multi-Drug Resistant Escherichia coli Isolates from North of Iran, Rasht</VernacularTitle>
			<FirstPage>69</FirstPage>
			<LastPage>78</LastPage>
			<ELocationID EIdType="pii">19550</ELocationID>
			
			
			<Language>FA</Language>
<AuthorList>
<Author>
					<FirstName>Tolou</FirstName>
					<LastName>Babaei Hematti</LastName>
<Affiliation>M.Sc. of Cellular and Molecular Biology, University of Guilan, University Compus 2, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad Javad</FirstName>
					<LastName>Mehdipour Moghaddam</LastName>
<Affiliation>Assistant Professor of Microbiology, University of Guilan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Zivar</FirstName>
					<LastName>Salehi</LastName>
<Affiliation>Professor of Molecular Genetics, University of Guilan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyyed Nahmood</FirstName>
					<LastName>Habibzadeh</LastName>
<Affiliation>Assistant Professor of Pathobiology, Razi pathobiology Labratoary, Rasht, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>06</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>&lt;strong&gt;Introduction&lt;/strong&gt;: One of the most important resistance determinants in Enterobacteriaceae are extended spectrum β-lactamases (ESBLs). During the last decade, CTX-M types ESBLs have increased considerably and become the most common ESBLs worldwide which are the major causes of the urinary tract infections (UTIs). The aim of this study was to determine the antibiotic resistance patterns and the frequency of the CTX-M β-lactamases among multi-drug resistant (MDR) &lt;em&gt;Escherichia coli &lt;/em&gt;(&lt;em&gt;E. coli&lt;/em&gt;)isolates from northern Iranian patients with UTI. &lt;br /&gt;&lt;strong&gt;Materials and method&lt;/strong&gt;s: Thirty three &lt;em&gt;E. coli&lt;/em&gt; isolates from urine samples were applied in this study. Double disk synergy test (DDST) was applied for identification of ESBL phenotypes in &lt;em&gt;E. coli&lt;/em&gt; isolates. The ESBL related genes, CTX-M group (1, 2, 8 and 9), were amplified by polymerase chain reaction (PCR). &lt;br /&gt;&lt;strong&gt;Results&lt;/strong&gt;: All &lt;em&gt;E. coli &lt;/em&gt;isolates showed sensitivity to piperacillin and 55% of the isolates were resistant to 3&lt;sup&gt;rd&lt;/sup&gt; and 4&lt;sup&gt;th&lt;/sup&gt; cephalosporins. The presence of the &lt;em&gt;bla&lt;/em&gt;&lt;sub&gt;CTX-M &lt;/sub&gt;gene in 88% of the ESBL producing isolates was approved based on molecular method. CTX-M (1, 2, 8 and 9) containing &lt;em&gt;E. coli&lt;/em&gt; isolates showed resistance to more antibiotics than non-CTX-M isolates. CTX-M-1 was the most prevalent CTX-M determinant in ESBL producing &lt;em&gt;E. coli &lt;/em&gt;isolates&lt;strong&gt;.&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;Discussion and conclusion&lt;/strong&gt;&lt;strong&gt;: &lt;/strong&gt;Based on the results of the present study, the preferred antibiotic against CTX-M type ESBL-producing&lt;em&gt; E. coli&lt;/em&gt; strains in north of Iran, Rasht, should be piperacillin. Although, CTX-M type ESBLs prevalence was nearly low in the studied MDR &lt;em&gt;E. coli&lt;/em&gt; isolates, but controlling these low prevalence isolates is important.</Abstract>
			<OtherAbstract Language="FA">&lt;strong&gt;Introduction&lt;/strong&gt;: One of the most important resistance determinants in Enterobacteriaceae are extended spectrum β-lactamases (ESBLs). During the last decade, CTX-M types ESBLs have increased considerably and become the most common ESBLs worldwide which are the major causes of the urinary tract infections (UTIs). The aim of this study was to determine the antibiotic resistance patterns and the frequency of the CTX-M β-lactamases among multi-drug resistant (MDR) &lt;em&gt;Escherichia coli &lt;/em&gt;(&lt;em&gt;E. coli&lt;/em&gt;)isolates from northern Iranian patients with UTI. &lt;br /&gt;&lt;strong&gt;Materials and method&lt;/strong&gt;s: Thirty three &lt;em&gt;E. coli&lt;/em&gt; isolates from urine samples were applied in this study. Double disk synergy test (DDST) was applied for identification of ESBL phenotypes in &lt;em&gt;E. coli&lt;/em&gt; isolates. The ESBL related genes, CTX-M group (1, 2, 8 and 9), were amplified by polymerase chain reaction (PCR). &lt;br /&gt;&lt;strong&gt;Results&lt;/strong&gt;: All &lt;em&gt;E. coli &lt;/em&gt;isolates showed sensitivity to piperacillin and 55% of the isolates were resistant to 3&lt;sup&gt;rd&lt;/sup&gt; and 4&lt;sup&gt;th&lt;/sup&gt; cephalosporins. The presence of the &lt;em&gt;bla&lt;/em&gt;&lt;sub&gt;CTX-M &lt;/sub&gt;gene in 88% of the ESBL producing isolates was approved based on molecular method. CTX-M (1, 2, 8 and 9) containing &lt;em&gt;E. coli&lt;/em&gt; isolates showed resistance to more antibiotics than non-CTX-M isolates. CTX-M-1 was the most prevalent CTX-M determinant in ESBL producing &lt;em&gt;E. coli &lt;/em&gt;isolates&lt;strong&gt;.&lt;/strong&gt; &lt;br /&gt;&lt;strong&gt;Discussion and conclusion&lt;/strong&gt;&lt;strong&gt;: &lt;/strong&gt;Based on the results of the present study, the preferred antibiotic against CTX-M type ESBL-producing&lt;em&gt; E. coli&lt;/em&gt; strains in north of Iran, Rasht, should be piperacillin. Although, CTX-M type ESBLs prevalence was nearly low in the studied MDR &lt;em&gt;E. coli&lt;/em&gt; isolates, but controlling these low prevalence isolates is important.</OtherAbstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">CTX-M</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">E. coli</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ESBL</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Multi-drug resistance</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Urinary tract infection</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://bjm.ui.ac.ir/article_19550_d788ac47cb8fdf90b8aa18130d83ee92.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
